ABVC BIOPHARMA INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.00
-3.85%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-2.0%
3 months
-3.9%
6 months
-2.9%
1 year
-64.5%
Year to date
-53.0%
52-week range
$0.71 – $2.99
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$26.7M
P/E
-3.8
P/B
2.6
P/S
—
Revenue
$0
Net income
-$7.11M
Diluted EPS
-0.29
Gross margin
—
Net margin
—
Return on equity
-64.30%
Total debt
$2.62M
Cash
$31.94K
Free cash flow
-$2.7M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$736.93K | — | — | -$244.41K |
| Mar 31, 2026 | $0 | -$1.56M | — | — | -$894.24K |
| Dec 31, 2025 | $0 | -$2.77M | — | — | -$593.38K |
| Sep 30, 2025 | $795.95K | -$1.25M | 100.00% | -156.60% | -$133.26K |
| Jun 30, 2025 | $0 | -$2.26M | — | — | -$894.17K |
| Mar 31, 2025 | $0 | -$842.08K | — | — | -$539.83K |
| Dec 31, 2024 | $1.97K | $229.3K | 100.00% | 11663.50% | -$493.61K |
| Sep 30, 2024 | $389.28K | -$186.56K | 99.90% | -47.90% | $171.72K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ABVC news
All market newsNo ticker-linked stories are in the current archive.